Q1 2019 Seres Therapeutics Inc Earnings Call Transcript
Good day, ladies and gentlemen. Thank you for standing by, and welcome to Q1 2019 Seres Therapeutics Earnings Conference Call. (Operator Instructions) As a reminder, this conference may be recorded.
At this time, I would like to turn the conference call over to Dr. Carlo Tanzi, Vice President of Investor Relations and Corporate Communications. You may begin.
Thank you, and good morning. A press release for the company's first quarter 2019 financial results and a business update became available at 7:00 a.m. Eastern Time this morning and can be found on the Investors & Media section of the company's website.
I would like to remind you that we'll be making forward-looking statements relating to the timing, enrollment and results of our clinical studies, including changes related to the design of our ECOSPOR III study, regulatory matters, study designs, our development plans, our potential competitive advantages, the promise and potential impact of our microbiome
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |